Login / Signup

Multimodal treatment according to the NPC-GPOH trials in adult patients with nasopharyngeal cancer-Analysis based on a single-center experience.

Martin LeuHanibal BohnenbergerManuel GuhlichMarkus Anton SchirmerYiannis PilavakisHendrik Andreas WolffStefan RiekenLeif Hendrik Dröge
Published in: Cancer reports (Hoboken, N.J.) (2024)
We found excellent outcomes and good feasibility of the NPC-GPOH trials regimen in adult patients. Additionally, we identified patients with outcomes which need to be improved (smokers, histologic type I tumors) and with particularly excellent outcomes (histologic type III tumors). This stimulates further studies on treatment intensification or de-escalation aiming at reduced side effects with optimal tumor control in NPC.
Keyphrases
  • type iii
  • type diabetes
  • clinical trial
  • smoking cessation
  • weight loss
  • squamous cell
  • double blind